Dupilumab and crisaborole for atopic dermatitis: effectiveness and value : final evidence report and meeting summary
- Collection:
-
Health Policy and Services Research
- Contributor(s):
-
Institute for Clinical and Economic Review, issuing body.
Midwest Comparative Effectiveness Public Advisory Council, issuing body.
- Publication:
-
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 8, 2017
- Language(s):
-
English
- Format:
-
Text
- Subject(s):
-
Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic -- drug therapy
Interleukin-4 Receptor alpha Subunit -- antagonists & inhibitors
Phosphodiesterase 4 Inhibitors -- therapeutic use
Antibodies, Monoclonal -- adverse effects
Cost-Benefit Analysis
Cyclosporine -- therapeutic use
Phosphodiesterase 4 Inhibitors -- adverse effects
Phototherapy
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Genre(s):
-
Technical Report
- Copyright:
-
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
-
1 online resource (1 PDF file (vi, ES22, 109 pages))
- Illustrations:
-
Illustrations
- NLM Unique ID:
-
101723893 (See catalog record)
- Permanent Link:
-
http://resource.nlm.nih.gov/101723893
